Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Benjamin L. Ebert, M.D., D.Phil.

Co-Author

This page shows the publications co-authored by Benjamin Ebert and Rob Sellar.
Connection Strength

1.881
  1. Predicting progression to AML. Nat Med. 2018 07; 24(7):904-906.
    View in: PubMed
    Score: 0.817
  2. The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K. Nature. 2020 09; 585(7824):293-297.
    View in: PubMed
    Score: 0.233
  3. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170.
    View in: PubMed
    Score: 0.216
  4. Jak-ing Up the Plaque's Lipid Core…and Even More. Circ Res. 2018 11 09; 123(11):1180-1182.
    View in: PubMed
    Score: 0.209
  5. PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. 2018 09 13; 132(11):1095-1105.
    View in: PubMed
    Score: 0.204
  6. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms. Sci Transl Med. 2018 04 11; 10(436).
    View in: PubMed
    Score: 0.201
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.